Lunai Bioworks LNAI
NASDAQ LNAI
$0.16 -0.08 (-33.33%)
At close: Oct 29, 2026 · 4:00 PM EDT

Lunai Bioworks (LNAI) Cost of Revenue (2013 - 2015)

Updated

Analysis

Lunai Bioworks (LNAI) Cost of Revenue (2013 - 2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,253.76 Bn 1,227.37 Bn 20.46 Bn 3.93 Bn
2 Johnson & Johnson 678.59 Bn 598.45 Bn 17.30 Bn 8.10 Bn
3 AbbVie 518.32 Bn 486.33 Bn 13.12 Bn 4.29 Bn
4 Merck 364.87 Bn 327.81 Bn 13.19 Bn 4.89 Bn
5 Novartis Ag 316.38 Bn 289.61 Bn - -
6 Astrazeneca 293.47 Bn 267.36 Bn 13.26 Bn 2.95 Bn
7 Amgen 250.73 Bn 202.38 Bn 7.58 Bn 2.79 Bn
8 Gilead Sciences 210.05 Bn 185.16 Bn 6.73 Bn 1.57 Bn
9 Pfizer 167.89 Bn 115.25 Bn 12.56 Bn 4.03 Bn
10 Lunai Bioworks 537,744.47 537,744.47 - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 5,244.00
Mar 31, 2015 44,622.00
Dec 31, 2014 70,161.00
Sep 30, 2014 143,495.00
Jun 30, 2014 64,266.00
Mar 31, 2014 17,739.00
Sep 30, 2013 16,198.00
Jun 30, 2013 36,928.00
Mar 31, 2013 15,360.00
API Access

Lunai Bioworks Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=LNAI&period=max&api_key=YOUR_API_KEY